Whilst clinical trials have shown modest improvements in cholesterol levels amongst patients using Ozempic, these changes appear largely secondary to weight loss rather than direct lipid-lowering effects
These findings suggest that once-weekly subcutaneous semaglutide, when combined with lifestyle interventions, offers superior weight loss benefits in individuals with overweight or obesity compared to once-daily subcutaneous liraglutide [10]
It also works by helping the body build intracellular levels of glutathione, which allows the liver to detox chemicals
Advanced Liposomal Delivery System
Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G